David Fernández-Justel

David Fernández-Justel

Auto-generated profile, based on publicly available information

David Fernández-Justel

Metabolic Engineering Group, Department of Microbiology and Genetics Universidad de Salamanca Salamanca Spain

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 April 2020 in eLife
Verified
Journal Article
Open access
APAnna Plana-Bonamaisó
Anna Plana-Bonamaisó
SLSantiago López-Begines
Santiago López-Begines
DFDavid Fernández-Justel
David Fernández-Justel
AJAlexandra Junza
Alexandra Junza
ASAriadna Soler-Tapia
Ariadna Soler-Tapia
AMAna Méndez
Ana Méndez
We report the in vivo regulation of Inosine-5´-monophosphate dehydrogenase 1 (IMPDH1) in the retina. IMPDH1 catalyzes the rate-limiting step in the de novo synthesis of guanine nucleotides, impacting the cellular pools of GMP, GDP and GTP. Guanine nucleotide homeostasis is central to photoreceptor cells, where cGMP is the signal transducing molecule in the light response. Mutations in IMPDH1 lead to inherited blindness. We unveil a light-dependent phosphorylation of retinal IMPDH1 at Thr159/Ser160 in the Bateman domain that desensitizes the enzyme to allosteric inhibition by GDP/GTP. When exposed to bright light, living mice increase the rate of GTP and ATP synthesis in their retinas; concomitant with IMPDH1 aggregate formation at the outer segment layer. Inhibiting IMPDH activity in living mice delays rod mass recovery. We unveil a novel mechanism of regulation of IMPDH1 in vivo, important for understanding GTP homeostasis in the retina and the pathogenesis of adRP10 IMPDH1 mutations.

10 January 2022 in Nature Structural & Molecular Biology
Verified
Journal Article
Closed access
PDF file
ABAnika L. Burrell
Anika L. Burrell
CNChuankai Nie
Chuankai Nie
MSMeerit Said
Meerit Said
JSJacqueline C. Simonet
Jacqueline C. Simonet
DFDavid Fernández-Justel
David Fernández-Justel
JKJustin M. Kollman
Justin M. Kollman

13 August 2022 in Protein Science
Verified
Journal Article
Open access
Rubén M. BueyRubén M. Buey
Rubén M. Buey
DFDavid Fernández‐Justel
David Fernández‐Justel
AJAlberto Jiménez
Alberto Jiménez
JRJosé Luis Revuelta
José Luis Revuelta
Inosine 5′‐monophosphate dehydrogenase (IMPDH) is an evolutionarily conserved enzyme that mediates the first committed step in de novo guanine nucleotide biosynthetic pathway. It is an essential enzyme in purine nucleotide biosynthesis that modulates the metabolic flux at the branch point between adenine and guanine nucleotides. IMPDH plays key roles in cell homeostasis, proliferation, and the immune response, and is the cellular target of several drugs that are widely used for antiviral and immunosuppressive chemotherapy. IMPDH enzyme is tightly regulated at multiple levels, from transcriptional control to allosteric modulation, enzyme filamentation, and posttranslational modifications. Herein, we review recent developments in our understanding of the mechanisms of IMPDH regulation, including all layers of allosteric control that fine‐tune the enzyme activity.

1 October 2019 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
DFDavid Fernández-Justel
David Fernández-Justel
RPRafael Peláez
Rafael Peláez
JRJosé Luis Revuelta
José Luis Revuelta
Rubén M. BueyRubén M. Buey
Rubén M. Buey
IMP dehydrogenase (IMPDH) is an essential enzyme that catalyzes the rate-limiting step in the de novo guanine nucleotide biosynthetic pathway. Because of its involvement in the control of cell division and proliferation, IMPDH represents a therapeutic for managing several diseases, including microbial infections and cancer. IMPDH must be tightly regulated, but the molecular mechanisms responsible for its physiological regulation remain unknown. To this end, we recently reported an important role of adenine and guanine mononucleotides that bind to the regulatory Bateman domain to allosterically modulate the catalytic activity of eukaryotic IMPDHs. Here, we have used enzyme kinetics, X-ray crystallography, and small-angle X-ray scattering (SAXS) methodologies to demonstrate that adenine/guanine dinucleoside polyphosphates bind to the Bateman domain of IMPDH from the fungus Ashbya gossypii with submicromolar affinities. We found that these dinucleoside polyphosphates modulate the catalytic activity of IMPDHs in vitro by efficiently competing with the adenine/guanine mononucleotides for the allosteric sites. These results suggest that dinucleoside polyphosphates play important physiological roles in the allosteric regulation of IMPDHs by adding an additional mechanism for fine-tuning the activities of these enzymes. We propose that these findings may have important implications for the design of therapeutic strategies to inhibit IMPDHs.